Immunological adjuvant and vaccine composition including sting agonist

Abstract

The present invention relates to an immunological adjuvant composition and a vaccine composition including a STING immunological adjuvant, and it is confirmed that the immunological adjuvant composition and vaccine composition including the STING agonist according to the present invention not only may effectively activate various body immune responses, but also have the effect of remarkably reducing the infection of Mycobacterium tuberculosis. Thus, it is expected that when they are used with vaccines against not only Mycobacterium tuberculosis but also other pathogens, they remarkably increase the effectiveness of the existing vaccine for preventing infection, thereby being capable of effectively reducing the infection of various pathogens.

Dependencies are inferred from the claim text.